文献速递肝病消化道肿瘤与早癌消化内镜

钆塞酸增强MRI的动脉减影图像改善早期肝细胞癌的诊断

Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma.
PubMed 文献 · J Hepatol · 2019-05-18

该回顾性研究纳入258例肝细胞癌风险患者共372个≤3.0 cm的肝脏结节,比较普通动脉期与动脉减影图像对动脉期高增强的检出率及LI-RADS v2018诊断早期肝细胞癌的效能。动脉减影图像显著提高动脉期高增强检出率和LI-RADS 5类诊断肝细胞癌的敏感度,且未显著降低特异度。

要点

  • 动脉减影图像对全部结节的动脉期高增强检出率为72.3%,高于普通动脉期图像的62.4%(p<0.001)。
  • 动脉减影图像对肝细胞癌的动脉期高增强检出率为91.9%,高于普通动脉期图像的80.6%(p<0.001)。
  • 动脉减影图像使LI-RADS 5类诊断肝细胞癌的敏感度从55.9%(151/270)升至64.1%(173/270),特异度无显著下降(92.9% vs 94.9%,p=0.155)。

核心结论

  • 钆塞酸增强MRI的动脉减影图像可显著提高基于LI-RADS的早期肝细胞癌诊断敏感度,且未显著降低特异度。

研究设计与样本

  • 回顾性分析2016年接受钆塞酸增强MRI的258例肝细胞癌风险患者,共372个≤3.0 cm的肝脏结节(273个肝细胞癌、18个其他恶性肿瘤、81个良性结节)。
  • 最终诊断依据组织病理学或临床标准(治疗后边缘复发或随访影像病灶大小变化)。

主要发现

  • 动脉减影图像对全部肝脏结节的动脉期高增强检出率为72.3%,高于普通动脉期图像的62.4%(p<0.001)。
  • 动脉减影图像对肝细胞癌的动脉期高增强检出率为91.9%,高于普通动脉期图像的80.6%(p<0.001)。
  • 动脉减影图像使LI-RADS 5类诊断肝细胞癌的敏感度从55.9%(151/270)升至64.1%(173/270)(p<0.001),特异度从94.9%(93/98)降至92.9%(91/98),差异无统计学意义(p=0.155)。
  • 对组织病理学确诊的病灶,动脉减影图像使敏感度从61.3%(114/186)升至68.8%(128/186)(p<0.001),特异度从89.1%(41/46)降至84.8%(39/46),差异无统计学意义(p=0.151)。

临床怎么用

  • 作者结论认为,钆塞酸增强MRI的动脉减影图像可显著提高基于LI-RADS的早期肝细胞癌诊断敏感度,且未显著降低特异度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Although gadoxetate disodium-enhanced magnetic resonance imaging (MRI) shows higher sensitivity for diagnosing hepatocellular carcinoma (HCC), its arterial-phase images may be unsatisfactory because of weak arterial enhancement. We investigated the clinical effectiveness of arterial subtraction images from gadoxetate disodium-enhanced MRI for diagnosing early-stage HCC using the Liver Imaging Reporting and Data System (LI-RADS) v2018. METHODS: In 258 patients at risk of HCC who underwent gadoxetate disodium-enhanced MRI in 2016, a total of 372 hepatic nodules (273 HCCs, 18 other malignancies, and 81 benign nodules) of 3.0 cm or smaller were retrospectively analyzed. Final diagnosis was assessed histopathologically or clinically (marginal recurrence after treatment or change in lesion size on follow-up imaging). The detection rate for arterial hyperenhancement was compared between ordinary arterial-phase and arterial subtraction images, and the benefit of arterial subtraction images in diagnosing HCC using LI-RADS was assessed. RESULTS: Arterial subtraction images had a significantly higher detection rate for arterial hyperenhancement than ordinary arterial-phase images, both for all hepatic nodules (72.3% vs. 62.4%, p <0.001) and HCCs (91.9% vs. 80.6%, p <0.001). Compared with ordinary arterial-phase images, arterial subtraction images significantly increased the sensitivity of LI-RADS category 5 for diagnosis of HCC (64.1% [173/270] vs. 55.9% [151/270], p <0.001), without significantly decreasing specificity (92.9% [91/98] vs. 94.9% [93/98], p = 0.155). For histopathologically confirmed lesions, arterial subtraction images significantly increased sensitivity to 68.8% (128/186) from the 61.3% (114/186) of ordinary arterial-phase images (p <0.001), with a minimal decrease in specificity to 84.8% (39/46) from 89.1% (41/46) (p = 0.151). CONCLUSIONS: Arterial subtraction images of gadoxetate disodium-enhanced MRI can significantly improve the sensitivity of early-stage HCC diagnosis using LI-RADS, without a significant decrease in specificity. LAY SUMMARY: Gadoxetate disodium-enhanced magnetic resonance imaging is an imaging technique with a high sensitivity for the diagnosis of hepatocellular carcinoma. However, arterial-phase images may be unsatisfactory because of weak arterial enhancement. We found that using arterial subtraction images led to clinically meaningful improvements in the diagnosis of early-stage hepatocellular carcinoma.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Kim DH, Choi SH, Byun JH, et al. Arterial subtraction images of gadoxetate-enhanced MRI improve diagnosis of early-stage hepatocellular carcinoma. J Hepatol. 2019. PMID: 31108157. doi:10.1016/j.jhep.2019.05.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。